Systemic lupus erythematosus (SLE) Musculoskeletal Diseases Systemic lupus erythematosus (SLE)
Conditions
Interventions
Allocation using a minimisation protocol to 12 weeks of either graded exercise therapy, relaxation therapy or no intervention
Sponsors
Arthritis Research Campaign (ARC) (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Female patients fulfilling American College of Rheumatology (ACR) classification for SLE
Exclusion criteria
Exclusion criteria: 1. Evidence of active severe myositis, nephritis, neurological involvement or cardiac or pulmonary disease 2. Pregnant patients 3. Patients under 16 or over 55 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-rated clinical global impression change score, measured at baseline and three months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessments of symptoms, measured at baseline and three months 2. Functional capacity, measured at baseline and three months 3. Fitness, measured at baseline and three months | — |
Countries
United Kingdom
Outcome results
None listed